Uniquely Qualified, World Class
Innovative and dynamic professional with +20 years of technical, entrepreneurial and leadership experience in Molecular Diagnostics and Precision Medicine.
Recent work focused on strategic advice to major global pharmaceutical and Dx companies, Investment Funds, VCs, and Governments on precision medicine strategies and on the effective integration of Dx and Rx into drug development and market adoption pathways. European Commission advisor. ASCO evaluator.
MD, PhD, MBA. Spare time devoted to collaborations with NGOs, having founded children’s NGOs in Africa and Europe. Enjoys travelling, cultural activities, music, arts, horseback riding, yoga, squash and tennis.
Strategic Advisor
Innovation leader with over 50 years of management experience in the electronics industry, having also multiple successful entrepreneur, investor and executive experiences as chairman (MIMS, RAMTRON, Reaction Design), CEO (AMCC, GGTI), board member (iBOSS, NetClearance Systems, HVVI, Mobileworks.com, MCHP, ONNN, AMKOR), COO (Burr Brown Research), and advisor (Don Valentin, Sequolia Partner, Founder and John Prior, Needham @Co).
MSEE, MBA.
Strategic Advisor
Strategic Advisor
Economist with extensive experience in strategic consulting (PWC, Accenture, E&Y, Everis), having held the position of Senior Partner and Global Director of the Digital Strategy Unit, and Senior Partner Public Sector & Global Health of Everis, and a member of its Global Management and Human Resources committees.
PAD.
Strategic Advisor
Medical Advisor
Medical Oncologist with over 30 years of scientific, clinical and patient experience including as Principal Investigator on several studies at MD Anderson Cancer Center and as Director of the International Patient Center and having served as board member and advisor to several biotechs and start ups in the Oncology and Diagnostics field in the US and Latam (Millenium Lymphoma, Celgene...).
MD, PA.
Medical Advisor
Strategic Advisor
Diagnostics and therapeutics mentor at the Wyss Institute, having over 35 years of experience in the medical device and pharmaceutical fields, focusing on innovation for companies such as Imclone Systems, BD, Roche Diagnostics, Johnson and Johnson and Novartis, as well as starting his own management consulting firm focused on the performance of due diligence and transactions.
Regards himself as a generalist who is able to integrate innovative science in the context of healthcare systems as complex business ecosystems with multiple stakeholders.
PhD.
Strategic Advisor
Advisor
Ex CEO of several NASDAQ Dx companies.
Managing director of VC Fund.
Advisor